Clinical Trial Update: Pegfilgrastim and Combination Chemotherapy With or Without Rituximab in Treating Older Patients With Aggressive B-Cell Non-Hodgkin Lymphoma [Phase 2]

View source ↗

Summary

Phase 2 trial update evaluating pegfilgrastim with combination chemotherapy, with or without rituximab, in older patients with aggressive B-cell non-Hodgkin lym…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Aggressive B-cell Non-hodgkin Lymphoma

Drugs mentioned

• Pegfilgrastim (pegfilgrastim)
• Rituximab (rituximab)

Snippet

Sponsor: Universität des Saarlandes | Conditions: Lymphoma | Phase 2 | Status: COMPLETED